BioSpace News Archive

Shares of Endo International are up more than 5% after the company announced positive earnings Thursday and also announced a new restructuring plan.

The demand within the global heart-lung machines market is expected to rise at a visible pace in the years to follow.

The global Immunohistochemistry and In situ hybridization slide staining systems market is expected to gain impetus from the advancement of the healthcare sector and introduction of karyotyping and others in the disease diagnostics department.

Graft delivery refers to the procedure in which a piece of living tissue is surgically transplanted.

The demand within the global spinal devices market is slated to ascend in the years to follow.

Enzalutamide is now NMPA-approved for both non-metastatic and metastatic castration-resistant prostate cancer

The Board of Directors of Moberg Pharma AB announces its intention to distribute the operations of BupiZenge® to the shareholders of Moberg Pharma by distributing 90 percent of the shares in a subsidiary through a so-called Lex ASEA distribution, and convenes an extraordinary general meeting to resolve accordingly.

Immunovia invites to a teleconference for investors, analysts and media on Thursday, November 12, 2020 at 16:30 CET.

Organized by Jeju Peace Institute, an annual international peace forum opened on the southern resort island of Jeju on Thursday, with a focus on ways to shore up multilateral cooperation in tackling the coronavirus pandemic and promoting regional security.

Thermo Fisher Scientific Inc., the world leader in serving science, and Innoforce, a bioinnovation-enabling company, announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing.